Galliford Try Holdings PLC (GFRD) is a leading residential construction business based in the UK. Galliford Try is listed on the London Stock Exchange (LSE) and employs 2,944 staff. All prices are listed in pence sterling.
|52-week range||70p - 199.4659p|
|50-day moving average||120.0394p|
|200-day moving average||97.1717p|
|Wall St. target price||1054p|
|Dividend yield||0.36p (26.25%)|
|Earnings per share (TTM)||289.2p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Galliford Try stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Galliford Try's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Galliford Try's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Galliford Try shares trade at around 0x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Galliford Try's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £168.5 million.
The EBITDA is a measure of a Galliford Try's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£1.1 billion|
|Gross profit TTM||£35.7 million|
|Return on assets TTM||-1.21%|
|Return on equity TTM||-8.15%|
|Market capitalisation||£144.4 million|
TTM: trailing 12 months
We're not expecting Galliford Try to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Galliford Try's shares were split on a 1:10 basis on 7 October 2009. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Galliford Try shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Galliford Try shares which in turn could have impacted Galliford Try's share price.
Over the last 12 months, Galliford Try's shares have ranged in value from as little as 70p up to 199.4659p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Galliford Try's is 1.4923. This would suggest that Galliford Try's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Galliford Try Holdings PLC, together with its subsidiaries, operates in the construction business in the United Kingdom. The company's Building division works with private and public sector clients in health, education, and defense. Its Infrastructure division carries out civil engineering projects in the highways and environment sectors. The company's PPP Investments division delivers various building and infrastructure projects through public-private partnerships and co-development opportunities. Its Facilities Management division provides services for buildings. Galliford Try Holdings PLC was incorporated in 2019 and is based in Uxbridge, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.